Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carolin Selenz"'
Autor:
Reinhard Büttner, Khosro Hekmat, David Kirsch, Michael Hallek, Birgit Gathof, Jana Fassunke, Asmae Gassa, Hakan Alakus, Sven Borchmann, Carolin Selenz, Mia Lohmann, Hanna Ludwig, Johannes Brägelmann, Philipp Lohneis, Lydia Meder, Julia Mattlener, Sara Breid, Marieke Nill, Amy J. Wisdom, Anik Compes, H. Christian Reinhardt, Roland T. Ullrich
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Background Single-agent immunotherapy has shown remarkable efficacy in selected cancer entities and individual patients. However, most patients fail to respond. This is likely due to diverse immunosuppressive mechanisms acting in a concerted way to s
Externí odkaz:
https://doaj.org/article/3195db6b915d4f2596d994cb921be8a5
Autor:
Caroline Volz, Sara Breid, Carolin Selenz, Alina Zaplatina, Kristina Golfmann, Lydia Meder, Felix Dietlein, Sven Borchmann, Sampurna Chatterjee, Maike Siobal, Jakob Schöttle, Alexandra Florin, Mirjam Koker, Marieke Nill, Luka Ozretić, Niklas Uhlenbrock, Steven Smith, Reinhard Büttner, Hui Miao, Bingcheng Wang, H. Christian Reinhardt, Daniel Rauh, Michael Hallek, Amparo Acker-Palmer, Lukas C. Heukamp, Roland T. Ullrich
Publikováno v:
Cell Reports, Vol 31, Iss 4, Pp - (2020)
Summary: Anti-angiogenic treatment targeting vascular endothelial growth factor (VEGF)-VEGFR2 signaling has shown limited efficacy in lung cancer patients. Here, we demonstrate that inhibition of VEGFR2 in tumor cells, expressed in ∼20% of non-squa
Externí odkaz:
https://doaj.org/article/facb3169b7084c8eb4f67f107da06c75
Publikováno v:
Frontiers in Genetics, Vol 8 (2017)
Telomeres are essential nucleoprotein structures at linear chromosomes that maintain genome integrity by protecting chromosome ends from being recognized and processed as damaged DNA. In addition, they limit the cell’s proliferative capacity, as pr
Externí odkaz:
https://doaj.org/article/26d6453f3975436683c21825a3321f22
Autor:
Sven Borchmann, Carolin Selenz, Mia Lohmann, Hanna Ludwig, Asmae Gassa, Johannes Brägelmann, Philipp Lohneis, Lydia Meder, Julia Mattlener, Sara Breid, Marieke Nill, Jana Fassunke, Amy J. Wisdom, Anik Compes, Birgit Gathof, Hakan Alakus, David Kirsch, Khosro Hekmat, Reinhard Büttner, H. Christian Reinhardt, Michael Hallek, Roland T. Ullrich
BackgroundSingle-agent immunotherapy has shown remarkable efficacy in selected cancer entities and individual patients. However, most patients fail to respond. This is likely due to diverse immunosuppressive mechanisms acting in a concerted way to su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bffce8a9976a1567d1be969cb128ee15
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85139753206
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85139753206
Autor:
Carolin Selenz, Anik Compes, Marieke Nill, Sven Borchmann, Margarete Odenthal, Alexandra Florin, Johannes Brägelmann, Reinhard Büttner, Lydia Meder, Roland T. Ullrich
Publikováno v:
Cancers; Volume 14; Issue 16; Pages: 3943
EGFR-driven non-small-cell lung cancer (NSCLC) patients are currently treated with TKIs targeting EGFR, such as erlotinib or osimertinib. Despite a promising initial response to TKI treatment, most patients gain resistance to oncogene-targeted therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0ffe3b9b49c0644b905fed26c36f661
https://doi.org/10.3390/cancers14163943
https://doi.org/10.3390/cancers14163943
Autor:
Luka Ozretić, Daniel Rauh, Lukas C. Heukamp, Roland T. Ullrich, Carolin Selenz, Sara Breid, Bingcheng Wang, Jakob Schöttle, H. Christian Reinhardt, Sampurna Chatterjee, Alexandra Florin, Mirjam Koker, Felix Dietlein, Reinhard Büttner, Michael Hallek, Steven Smith, Kristina Golfmann, Lydia Meder, Alina Zaplatina, Caroline Volz, Maike Siobal, Hui Miao, Amparo Acker-Palmer, Sven Borchmann, Niklas Uhlenbrock, Marieke Nill
Publikováno v:
Cell Rep
Cell Reports, Vol 31, Iss 4, Pp-(2020)
Cell Reports, Vol 31, Iss 4, Pp-(2020)
Summary: Anti-angiogenic treatment targeting vascular endothelial growth factor (VEGF)-VEGFR2 signaling has shown limited efficacy in lung cancer patients. Here, we demonstrate that inhibition of VEGFR2 in tumor cells, expressed in ∼20% of non-squa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e41562252d214461eacecf75f9c462
https://hdl.handle.net/21.11116/0000-0008-0C46-D
https://hdl.handle.net/21.11116/0000-0008-0C46-D
Publikováno v:
Frontiers in Genetics, Vol 8 (2017)
Frontiers in Genetics
Frontiers in Genetics
Telomeres are essential nucleoprotein structures at linear chromosomes that maintain genome integrity by protecting chromosome ends from being recognized and processed as damaged DNA. In addition, they limit the cell’s proliferative capacity, as pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a0356ced88b17b21056ddf1f9bc710c
http://journal.frontiersin.org/article/10.3389/fgene.2017.00067/full
http://journal.frontiersin.org/article/10.3389/fgene.2017.00067/full